QuidelOrtho Corp. Stock
€39.40
Your prediction
QuidelOrtho Corp. Stock
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
Cons
Performance of QuidelOrtho Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp. | -0.520% | 0.000% | 7.065% | -51.274% | -41.905% | -58.933% | - |
Boston Scientific | 1.450% | 1.449% | 2.190% | 44.868% | 36.081% | 99.373% | 102.869% |
Waters Corp. | -1.360% | -4.765% | 7.554% | 29.917% | 3.245% | 19.008% | 71.168% |
Illumina Inc. | -0.110% | -3.944% | -14.474% | -50.379% | -23.619% | -70.285% | -65.071% |
Comments
News
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s
QuidelOrtho Reports First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and